You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial
|
|---|---|
| Published in |
Journal of Pharmaceutical Policy and Practice, January 2021
|
| DOI | 10.1186/s40545-020-00279-3 |
| Pubmed ID | |
| Authors |
Nadia Farhanah Syafhan, Sayer Al Azzam, Steven D. Williams, Wendy Wilson, Jayne Brady, Peter Lawrence, Mark McCrudden, Mustafa Ahmed, Michael G. Scott, Glenda Fleming, Anita Hogg, Claire Scullin, Robert Horne, Harblas Ahir, James C. McElnay |
X Demographics
The data shown below were collected from the profiles of 59 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 28 | 47% |
| Spain | 5 | 8% |
| United States | 3 | 5% |
| Australia | 2 | 3% |
| Ireland | 1 | 2% |
| Unknown | 20 | 34% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 41 | 69% |
| Practitioners (doctors, other healthcare professionals) | 9 | 15% |
| Scientists | 6 | 10% |
| Science communicators (journalists, bloggers, editors) | 3 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 69 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 9 | 13% |
| Student > Ph. D. Student | 7 | 10% |
| Student > Bachelor | 5 | 7% |
| Lecturer | 4 | 6% |
| Other | 4 | 6% |
| Other | 7 | 10% |
| Unknown | 33 | 48% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 14% |
| Medicine and Dentistry | 10 | 14% |
| Nursing and Health Professions | 5 | 7% |
| Business, Management and Accounting | 4 | 6% |
| Social Sciences | 4 | 6% |
| Other | 4 | 6% |
| Unknown | 32 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 43. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2022.
All research outputs
#974,201
of 25,537,395 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#12
of 521 outputs
Outputs of similar age
#26,968
of 522,417 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#2
of 20 outputs
Altmetric has tracked 25,537,395 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 521 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 522,417 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.